Sleepiz launches contactless device for remote patient monitoring in the United States; appoints Robb LaChappelle as vice president for the United States

ByLance T. Lee

Jul 14, 2022

FDA listing paves the way for Sleepiz to enter the US market and enables non-contact, in-home measurement of respiration and heart rate for remote patient monitoring and innovative medical study design

ZURICH, July 14, 2022 /PRNewswire/ — SwissMedical technology company Sleepiz has registered its Sleepiz One+ non-contact breathing and heart rate measuring device with the FDA. After the company’s successful market launch in Europe and IndiaFDA listing clears way for Sleepiz to offer its remote patient monitoring and clinical trial solution in United States.

Sleepiz One+ monitors breathing during sleep with 99% accuracy

Sleepiz One+ is one of the first breathing monitoring devices to track and record contactless patient data during sleep. Sleepiz’s technology enables entirely new insights into patient health, as clinicians no longer have to rely on one-off measurements but have access to continuous data. This new depth of information makes it possible to detect changes in respiratory rate, which can be an early predictor of diseases like pneumonia and cardiac arrest, or indicate an exacerbation in patients with chronic lung disease.

The FDA listing allows Sleepiz partners to United States to use Sleepiz One+ for remote patient monitoring and to integrate the device into clinical study platforms to monitor respiratory rate in a convenient and clinically validated way. US physicians can prescribe Sleepiz One+ to their patients to measure their short-term and long-term vital signs, allowing them to better understand the physiological status of patients. For patients, Sleepiz One+ brings a convenient new way of continuous monitoring at home by simply placing a small device on their bedside table, while they rest.

To drive Sleepiz’s market strategy by United Statesthe company has appointed Robb LaChappelle as Vice President of Sleepiz UNITED STATES. Mr. LaChappelle is an accomplished business development leader with extensive experience in the areas of medical devices, remote patient monitoring, life sciences and sleep. He has previously worked with innovators such as Nonin Medical and Vital Images (Canon Medical) as well as global players such as Silicon Graphics/SGI (Hewlett Packard) and Honeywell.

Sleepiz CEO Soumya Dash said, “We are delighted to welcome Robb to our leadership team and, with him, to extend the success of our business to the US market. Robb will lead the development of our operations in United States and work closely with our local partners to bring the benefits of our technology to patients, physicians and researchers.”

Sleepiz US Vice President Robb LaChappelle said, “Sleepiz offers a truly innovative solution that delivers a new level of patient comfort while meeting the highest standards for data accuracy. . I look forward to working with the founders of the company. on establishing and growing our presence in United States.”

Product visuals and portraits are available for download at

About Sleepiz

Sleepiz AG (Ltd.) is a Zürich, Switzerlandis a medical technology company whose mission is to provide patient-centric disease management through the seamless integration of contactless monitoring into people’s homes. Sleepiz harnesses the power of sleep insights with a device that’s simply placed on the bedside table. The device operates without contact and measures motion from heart contractions and breathing patterns, as well as body motion with medical-grade accuracy. While initially focusing on respiratory diseases, Sleepiz aims to improve people’s lives by creating the future of healthcare. Using millimeter wave wireless technology, sensor fusion and artificial intelligence, Sleepiz will not only be able to diagnose sleep disorders, but also perform long-term monitoring in the future. This will allow monitoring of chronic disease progression for faster intervention and better treatment.

Photo –

Media contact:
Oppenheim & Partner GmbH
Marash Pulaj
Stockerstraße 32, CH-8002 Zürich
+41 44 515 65 00
[email protected]

Contact Sleepiz:
Robb LaChapelle
Vice President Sleepiz USA
[email protected]



View original content for multimedia download: -lachappelle-as-vp-for-the-us-301586629.html


Source link